WIC
WealthBridge Investment Counsel Portfolio holdings
AUM
$308M
This Quarter Return
+13.1%
1 Year Return
+19.56%
3 Year Return
+62%
5 Year Return
+107.26%
10 Year Return
–
AUM
$229M
AUM Growth
+$229M
(+20%)
Cap. Flow
+$16.6M
Cap. Flow
% of AUM
7.24%
Top 10 Holdings %
Top 10 Hldgs %
40.05%
Holding
49
New
9
Increased
29
Reduced
11
Closed
–
Top Buys
| 1 |
Commercial Metals
CMC
|
$3.48M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$1.53M |
| 3 |
Danaher
DHR
|
$1.18M |
| 4 |
Exxon Mobil
XOM
|
$893K |
| 5 |
Weyerhaeuser
WY
|
$823K |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$953K |
| 2 |
iShares MSCI EAFE ETF
EFA
|
$428K |
| 3 |
Intel
INTC
|
$196K |
| 4 |
Merck
MRK
|
$155K |
| 5 |
MetLife
MET
|
$150K |
Sector Composition
| 1 | Healthcare | 25.61% |
| 2 | Financials | 18.56% |
| 3 | Industrials | 12.09% |
| 4 | Technology | 10.01% |
| 5 | Consumer Discretionary | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
JPMorgan Chase
JPM
$829B
| $10.2M | 4.44% | 75,741 +440 | +0.6% | +$59K |
|
|
2
iShares MSCI EAFE ETF
EFA
$66B
| $10.2M | 4.44% | 154,730 -6,515 | -4% | -$428K |
|
|
3
Merck
MRK
$210B
| $9.84M | 4.3% | 88,650 -1,400 | -2% | -$155K |
|
|
4
iShares MSCI Emerging Markets ETF
EEM
$19B
| $9.79M | 4.28% | 258,370 -25,150 | -9% | -$953K |
|
5
Visa
V
$683B
| $9.16M | 4.01% | 44,079 +1,073 | +2% | +$223K |
|
6
Goldman Sachs
GS
$226B
| $9.12M | 3.99% | 26,565 -140 | -0.5% | -$48.1K |
|
7
Apple
AAPL
$3.45T
| $8.67M | 3.79% | 66,710 +5,112 | +8% | +$664K |
|
|
8
MetLife
MET
$54.1B
| $8.66M | 3.79% | 119,725 -2,075 | -2% | -$150K |
|
9
Labcorp
LH
$23.1B
| $8.24M | 3.6% | 34,976 -150 | -0.4% | -$35.3K |
|
10
Eaton
ETN
$136B
| $7.79M | 3.41% | 49,620 -235 | -0.5% | -$36.9K |
|
11
CVS Health
CVS
$92.8B
| $7.66M | 3.35% | 82,173 +2,065 | +3% | +$192K |
|
12
Oracle
ORCL
$635B
| $7.43M | 3.25% | 90,853 +3,712 | +4% | +$303K |
|
13
Starbucks
SBUX
$100B
| $7.25M | 3.17% | 73,125 +2,060 | +3% | +$204K |
|
14
Gilead Sciences
GILD
$140B
| $6.79M | 2.97% | 79,055 +1,700 | +2% | +$146K |
|
15
Abbott
ABT
$231B
| $6.75M | 2.95% | 61,495 +1,475 | +2% | +$162K |
|
16
Northrop Grumman
NOC
$84.5B
| $6.31M | 2.76% | 11,565 -65 | -0.6% | -$35.5K |
|
17
Constellation Brands
STZ
$28.5B
| $6.08M | 2.66% | 26,245 +950 | +4% | +$220K |
|
18
Vanguard FTSE Europe ETF
VGK
$26.8B
| $5.95M | 2.6% | 107,285 +1,550 | +1% | +$85.9K |
|
19
Medtronic
MDT
$119B
| $5.73M | 2.5% | 73,660 +3,000 | +4% | +$233K |
|
20
AbbVie
ABBV
$372B
| $5.55M | 2.43% | 34,344 +1,188 | +4% | +$192K |
|
21
FedEx
FDX
$54.5B
| $5.47M | 2.39% | 31,568 +1,713 | +6% | +$297K |
|
22
Walt Disney
DIS
$213B
| $5.43M | 2.37% | 62,471 +3,235 | +5% | +$281K |
|
23
Citigroup
C
$178B
| $5.12M | 2.24% | 113,284 +17,625 | +18% | +$797K |
|
24
Verizon
VZ
$186B
| $5.07M | 2.22% | 128,603 +16,275 | +14% | +$641K |
|
25
Thermo Fisher Scientific
TMO
$186B
| $4.88M | 2.13% | 8,855 +728 | +9% | +$401K |
|